LSA
ICPT

Leonteq Securities AG’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Leonteq Securities AG’s Portfolio ICPT Stock Details ICPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-16,738
Closed -$185K – 1312
2023
Q2 		$185K Sell
16,738
-21,188
-56% -$295K 0.01% 553
2023
Q1 		$509K Buy
37,926
+9,600
+34% +$166K 0.02% 371
2022
Q4 		$350K Sell
28,326
-11,363
-29% -$161K 0.01% 443
2022
Q3 		$554K Sell
39,689
-74
-0.2% -$1.19K 0.02% 354
2022
Q2 		$549K Sell
39,763
-5,559
-12% -$89K 0.02% 375
2022
Q1 		$737K Buy
45,322
+2,008
+5% +$31.5K 0.03% 354
2021
Q4 		$706K Buy
43,314
+3,360
+8% +$56.6K 0.03% 400
2021
Q3 		$593K Sell
39,954
-10,355
-21% -$166K 0.03% 387
2021
Q2 		$1M Buy
50,309
+1,869
+4% +$37.1K 0.06% 269
2021
Q1 		$1.12M Buy
48,440
+6,454
+15% +$180K 0.07% 240
2020
Q4 		$1.04M Buy
+41,986
New +$1.39M 0.06% 268

Other funds holding ICPT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JFG
Jefferies Financial Group New York $14.6B AUM 40.95% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return

Leonteq Securities AG's ICPT Position: Q3 2023 in Review

Leonteq Securities AG sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q3 2023, closing a stake of 16,738 shares — an estimated $185K sold.

Leonteq Securities AG first reported a position in ICPT in Q4 2020 and held it in 11 quarters. The position peaked at $1.12M in Q1 2021. 146 funds tracked by Wall St. Rank hold ICPT as of Q3 2023.

  • Leonteq Securities AG reported no remaining Intercept Pharmaceuticals, Inc. position as of Q3 2023 after selling out during the quarter.
  • Leonteq Securities AG sold 16,738 Intercept Pharmaceuticals, Inc. shares in Q3 2023, an estimated $185K.
  • Leonteq Securities AG first reported a position in Intercept Pharmaceuticals, Inc. in Q4 2020 and held it in 11 quarters.
  • Leonteq Securities AG's Intercept Pharmaceuticals, Inc. position peaked at $1.12M in Q1 2021.
  • 146 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q3 2023.

Based on Leonteq Securities AG's 13F filing for Q3 2023, filed 11 Mar 2026.